Cyclophilin A as a Pro-Inflammatory Factor Exhibits Embryotoxic and Teratogenic Effects during Fetal Organogenesis

Int J Mol Sci. 2023 Jul 10;24(14):11279. doi: 10.3390/ijms241411279.

Abstract

The precise balance of Th1, Th2, and Th17 cytokines is a key factor in successful pregnancy and normal embryonic development. However, to date, not all humoral factors that regulate and influence physiological pregnancy have been completely studied. Our data here pointed out cyclophilin A (CypA) as the adverse pro-inflammatory factor negatively affecting fetal development and associated with pregnancy complications. In different mouse models in vivo, we demonstrated dramatic embryotoxicity and teratogenicity of increased CypA levels during pregnancy. Using generated transgenic models, we showed that CypA overexpression in fetal tissues induced the death of all transgenic fetuses and complete miscarriage. Administration of recombinant human CypA in a high dose to pregnant females during fetal organogenesis (6.5-11.5 dpc) exhibited teratogenic effects, causing severe defects in the brain and bone development that could lead to malformations and postnatal behavioral and cognitive disorders in the offspring. Embryotoxic and teratogenic effects could be mediated by CypA-induced up-regulation of M1 macrophage polarization via activation of the STAT1/3 signaling pathways. Here, we propose secreted CypA as a novel marker of complicated pregnancy and a therapeutic target for the correction of pregnancy complications.

Keywords: Cyclophilin A; complicated pregnancy; embryotoxicity; fetal anatomical defects; miscarriage; organogenesis; pro-inflammatory factor; teratogenicity; transgenic mice.

MeSH terms

  • Animals
  • Cyclophilin A* / genetics
  • Cyclophilin A* / metabolism
  • Female
  • Fetus / metabolism
  • Humans
  • Mice
  • Organogenesis
  • Pregnancy
  • Pregnancy Complications*
  • Signal Transduction
  • Teratogenesis*

Substances

  • Cyclophilin A